Market Samachar

Arcturus Therapeutics Holdings Inc. (ARCT) Discusses Phase II Data for OTC Deficiency and Advances in mRNA Liver Therapeutics Platform Transcript

Read full article on seekingalpha.com ↗

Market Samachar is a news aggregator. This article was originally published by seekingalpha.com. Tap the button above to read the full story on their site.

• COMPANIES Billionaire Ambani's Reliance Industries eyes Rs 10,000 cr debt fundraise: Sources Stocks-Markets-Economic Times
• COMPANIES PB Fintech shares crash 30%, bloodbath wipes off Rs 26,200 cr from m-cap after IRDAI’s reform plans. What Citi and Jefferies are warning Stocks-Markets-Economic Times
• COMPANIES Why is market falling today? Sensex plummets over 1,200 points, Nifty below 23,100. 5 factors behind bloodbath on D-Street Stocks-Markets-Economic Times
• INDIAN Insurance stocks tumble as IRDAI proposes overhaul of distribution economics Share Market Today
• INDIAN Nazara Technologies Ltd spurts 1.06%, rises for third straight session Share Market Today
• INDIAN NTPC Green Energy Ltd soars 0.23%, gains for fifth straight session Share Market Today
• INDIAN Hero Motors Ltd leads gainers in 'B' group Share Market Today
• INDIAN India Glycols Ltd leads gainers in 'A' group Share Market Today

More from Market Samachar

• Is 'out of control' US tipping culture spreading overseas? BBC News
• Traders are skeptical of Iran timeline for Strait of Hormuz reopening Finance
• Stocks making the biggest moves after hours: Snowflake, Marvell Technology, Agilent Technologies & more Finance
• Boeing CEO says company met requirements to increase 737 Max production to 47 jets per month Business News
• Abercrombie shares jump 12% on earnings beat even as Iran conflict hits sales Business News